Applications for Leave

Decision Information

Decision Content

No 41821     

 

 

Le 11 décembre 2025

 

December 11, 2025

 

 

 

 

ENTRE :

 

Groupe Jean Coutu (PJC) inc. et Pro Doc Ltée

 

Demanderesses

- et -

 

Sa Majesté le Roi du chef de la province de la Colombie-Britannique, Apotex Inc., Apotex Pharmaceutical Holdings, Inc., Bristol-Myers Squibb Canada, Bristol-Myers Squibb Company, Ethypharm Inc., Janssen Inc., Johnson & Johnson, Teva Canada Innovation S.E.N.C., Teva Canada Limited, Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Actavis Pharma Company, Joddes Limited, Ranbaxy Pharmaceuticals Canada Inc., Sun Pharmaceutical Industries Ltd., Pharmascience Inc., Hikma Labs Inc., Hikma Pharmaceuticals plc, West-Ward Columbus Inc., Sanis Health Inc., Shoppers Drug Mart Inc., Sandoz Canada Inc., Valeant Canada s.e.c., Bausch Health Companies Inc., Imperial Distributors Canada Inc., Kohl & Frisch Limited, Kohl & Frisch Distribution Inc., Amerisourcebergen Canada Corporation, United Pharmacists Manitoba Inc., Procurity Inc., Procurity Pharmacy Services Inc., Unipharm Wholesale Drugs Ltd., McKesson Corporation, McKesson Canada Corporation, Nu-Quest Distribution Inc., LPG Inventory Solutions, Abbott Laboratories Inc., Loblaw Companies Limited et Noramco Inc.

Intimés

 

 

BETWEEN:

 

Groupe Jean Coutu (PJC) inc. and Pro Doc Ltd.

Applicants

- and -

 

His Majesty the King in Right of the Province of British Columbia, Apotex Inc., Apotex Pharmaceutical Holdings, Inc., Bristol-Myers Squibb Canada, Bristol-Myers Squibb Company, Ethypharm Inc., Janssen Inc., Johnson & Johnson, Teva Canada Innovation G.P., Teva Canada Limited, Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Actavis Pharma Company, Joddes Limited, Ranbaxy Pharmaceuticals Canada Inc., Sun Pharmaceutical Industries Ltd., Pharmascience Inc., Hikma Labs Inc., Hikma Pharmaceuticals plc, West-Ward Columbus Inc., Sanis Health Inc., Shoppers Drug Mart Inc., Sandoz Canada Inc., Valeant Canada L.P., Bausch Health Companies Inc., Imperial Distributors Canada Inc., Kohl & Frisch Limited, Kohl & Frisch Distribution Inc., Amerisourcebergen Canada Corporation, United Pharmacists Manitoba Inc., Procurity Inc., Procurity Pharmacy Services Inc., Unipharm Wholesale Drugs Ltd., McKesson Corporation, McKesson Canada Corporation, Nu-Quest Distribution Inc., LPG Inventory Solutions, Abbott Laboratories Inc., Loblaw Companies Limited and Noramco Inc.

Respondents

 

 

 

JUGEMENT

 

La demande d’autorisation d’appel de l’arrêt de la Cour d’appel de la Colombie-Britannique (Vancouver), numéros CA49089 et CA49091, 2025 BCCA 80, daté du 19 mars 2025, est rejetée avec dépens en faveur de l’intimé Sa Majesté le Roi du chef de la province de la Colombie-Britannique.

 

Le juge Jamal n’a pas participé au jugement.

 

 

JUDGMENT

 

The application for leave to appeal from the judgment of the Court of Appeal for British Columbia (Vancouver), Numbers CA49089 and CA49091, 2025 BCCA 80, dated March 19, 2025, is dismissed with costs to the respondent His Majesty the King in Right of the Province of British Columbia.

 

Justice Jamal took no part in the judgment.

 

 

 

 

 

 

 

J.C.C.

C.J.C.

 You are being directed to the most recent version of the statute which may not be the version considered at the time of the judgment.